Cue Biopharma, Inc. Unrealized Gain (Loss) on Investments
Cue Biopharma, Inc. (CUE) reported Unrealized Gain (Loss) on Investments of $5.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2024-03-28
- Cue Biopharma, Inc. unrealized gain (loss) on investments for the quarter ending 2023-06-30 was -$34.00K.
- Cue Biopharma, Inc. unrealized gain (loss) on investments for the quarter ending 2023-03-31 was $39.00K.
- Cue Biopharma, Inc. unrealized gain (loss) on investments for fiscal 2022 was $96.00K, a 1246.23% increase from fiscal 2021.
- Cue Biopharma, Inc. unrealized gain (loss) on investments for fiscal 2021 was $7.13K, a 59.14% decline from fiscal 2020.
- Cue Biopharma, Inc. unrealized gain (loss) on investments for fiscal 2020 was $17.45K, a 2639.72% increase from fiscal 2019.
- Cue Biopharma, Inc. unrealized gain (loss) on investments for fiscal 2019 was $637.00.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|
| 2023-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $5.00K 10-Q · filed 2023-08-08 | ||
| 2023-03-31 | $39.00K 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $96.00K 10-K · filed 2024-03-28 | $95.87K 10-K · filed 2023-03-21 | ||
| 2021-12-31 | $7.13K 10-K · filed 2023-03-21 | |||
| 2020-12-31 | $17.45K 10-K · filed 2022-03-16 | |||
| 2019-12-31 | $637.00 10-K · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |